MedTrace Logo

Doxycycline- and Furazolidone-containing Quadruple Regimen is Superior of Tailored Therapy

NCT02894268 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2018-09-05

No results posted yet for this study

Summary

Doxycycline- and Furazolidone-containing Quadruple Regimen can be a successful rescue treatment for Helicobacter pylori Infection patients after Failure of several therapy. It is superior of tailored therapy as rescue treatment for helicobacter pylori Infection after failure of several therapy.

Conditions

  • Helicobacter Pylori Infection

Interventions

DRUG

Doxycycline

Doxycycline 100g po bid

DRUG

Furazolidone

Furazolidone 100mg po bid

DRUG

Esomeprazole

Esomeprazole 20mg po bid

DRUG

Colloidal Bismuth Subcitrate

Bismuth 20mg po bid

DRUG

Sensitivity antibiotics

Two antibiotics based on antibiotic sensitivity of H.pylori culture, including amoxicillin, clarithromycin, metronidazole, levofloxacin, tetracycline and furazolidone.

Sponsors & Collaborators

  • Sir Run Run Shaw Hospital

    lead OTHER

Principal Investigators

  • Weiling Hu, Attending · Sir Run Run Shaw Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2018-10-31
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02894268 on ClinicalTrials.gov